- Previous Close
122.90 - Open
119.90 - Bid 120.40 x 50000
- Ask 121.60 x 50000
- Day's Range
119.90 - 119.90 - 52 Week Range
119.90 - 166.80 - Volume
25 - Avg. Volume
65 - Market Cap (intraday)
7.929B - Beta (5Y Monthly) 0.59
- PE Ratio (TTM)
23.79 - EPS (TTM)
5.04 - Earnings Date May 1, 2025
- Forward Dividend & Yield 1.71 (1.30%)
- Ex-Dividend Date Feb 5, 2025
- 1y Target Est
--
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
www.aptar.com13,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: AGT.F
View MorePerformance Overview: AGT.F
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AGT.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AGT.F
View MoreValuation Measures
Market Cap
8.08B
Enterprise Value
8.86B
Trailing P/E
24.26
Forward P/E
24.51
PEG Ratio (5yr expected)
4.16
Price/Sales (ttm)
2.53
Price/Book (mrq)
3.58
Enterprise Value/Revenue
2.70
Enterprise Value/EBITDA
12.43
Financial Highlights
Profitability and Income Statement
Profit Margin
10.45%
Return on Assets (ttm)
7.20%
Return on Equity (ttm)
15.57%
Revenue (ttm)
3.58B
Net Income Avi to Common (ttm)
374.54M
Diluted EPS (ttm)
5.04
Balance Sheet and Cash Flow
Total Cash (mrq)
226.18M
Total Debt/Equity (mrq)
43.97%
Levered Free Cash Flow (ttm)
316.78M